Boston Scientific Corporation <BSX.N>: Wells Fargo cuts target price to $50 from $55
BSX•Related News
HNI Q2 FY26 GAAP EPS drops 31% to $0.70; net sales more than double to $1.5 billion
HNI•
Canada Goose beats quarterly revenue estimates on steady demand
GOOS•
Ranpak Q2 revenue beats analyst estimates on automation growth
PACK•
ICE 2Q FY26 GAAP diluted EPS rises 14% y/y to $1.69; net revenues climb 5% y/y to $2.7 billion
ICE•
NextDecade Provides Second Quarter 2026 Business Update
NEXT•